Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Maintains a 'Buy' on Medicis (MRX); Near-Term Noise, but Broader Thesis Still Intact
-
Canaccord Genuity Maintains a 'Buy' on BioMimetic Therapeutics (BMTI); Q3/11 Results Provide Little Clarity Into FDA Mindset for Augment
-
Canaccord Genuity Cuts Number On Universal Display (PANL) Despite Q3 'Beat'
-
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); EU Doc Call Takeaways: Choppy EU Waters Ahead for Esbriet
-
Canaccord Genuity Maintains a 'Hold' on Rubicon Technology (RBCN); Continued Softness in Pricing and Volumes
-
Canaccord Genuity Maintains a 'Hold' on Fuel-Tech (FTEK); Nice Execution in a Tough Tape
-
Canaccord Genuity Maintains a 'Hold' on ESCO Technologies (ESE); Betting on a Bounce in '13
-
Canaccord Genuity Maintains a 'Buy' on Nexxus Lighting (NEXS); Slow Initial Sell Through in Consumer Channel, but L-T Lighting Thesis Remains
-
Canaccord Genuity Maintains a 'Buy' on Rovi Corp. (ROVI); Outlook Declines on Weakness in Non-core Segments
-
Canaccord Genuity Reiterates a 'Buy' on Oasis Petroleum (OAS); Optimizing Asset Base for Cost-efficient Execution in 2012
-
Canaccord Genuity Maintains a 'Hold' on SandRidge Energy (SD); Lowering PT on Higher Capital Intensity and Higher Gas Composition
-
Orosur Mining Inc. Receives Water Exploration Permit for Pantanillo Project in Chile
-
Sagittarius Capital Announces Results of AGM Voting, Resignation of Board Member and Amended and Restated LOI
-
Sagittarius Capital Announces Results of AGM Voting, Resignation of Board Member and Amended and Restated LOI
-
Kips Bay Medical to Present at Two Upcoming Health Care Investor Conferences
-
Canaccord Genuity Maintains a 'Buy' on Synta Pharma. (SNTA); Q3/11 Update
-
Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Q3: We Expect Enox PI to Hold, Generic Copaxone Trial Ruling in Mid-2012
-
Canaccord Genuity Reiterates a 'Buy' on Hologic (HOLX); Upside FQ4; Attractive at Current Levels
-
Canaccord Genuity Maintains a 'Hold' on Allos Therapeutics (ALTH); Folotyn Sales Growth Slows
-
Canaccord Genuity Maintains a 'Hold' on Fuel-Tech (FTEK); Q3 First Look: Upside Surprise
-
Canaccord Genuity Maintains a 'Buy' on Finish Line (FINL); Management Meeting Points to Strong Momentum
-
Canaccord Genuity Maintains a 'Buy' on Pioneer Natural Resources (PXD); Lowering PT on Equity Offering; '12 Funding Gap Now Closed
-
Canaccord Genuity Maintains a 'Buy' on Cimarex Energy (XEC); Reducing PT on Lower Capital Productivity and Lower '12E Capex
-
Canaccord Genuity Maintains a 'Buy' on EOG Resources (EOG); Q3/11: Strong Operational Execution Underpinned by Eagle Ford/Wolfcamp
-
Eastern Platinum Limited: Operations at Crocodile River Mine Suspended After Fatal Accident
-
Eastern Platinum Limited: Operations at Crocodile River Mine Suspended After Fatal Accident
-
DexCom To Present at Upcoming Investor Conferences
-
Universal Display (PANL) Shares Hit on a Couple Negative Items Ahead of EPS
-
Fitch Rates Level 3 Financing Term Loan B III 'BB/RR1'; Outlook Positive
-
Canaccord Genuity Reaffirms a 'Buy' on Teva Pharma (TEVA); Quantifying the "Inflection" Point From Here - Attractive Path
-
Canaccord Genuity Maintains a 'Buy' on Pharmasset (VRUS); Stellar Interferon-free HCV Cure Rates Obtained
-
Canaccord Genuity Maintains a 'Buy' on Warner Chilcott (WCRX); Upside Case Remains with Outlook Intact Post Q3 and Sell-off
-
Canaccord Genuity Reiterates a 'Buy' on Inhibitex (INHX); New 7-day Data Significantly Mitigates 189 Risk
-
UPDATE - Canaccord Genuity Downgrades Medifast (MED) to Hold; Earnings Growth Could be Elusive for Some Time
-
Canaccord Genuity Maintains a 'Buy' on Concho Resources (CXO); Q3/11: Shifting to the Delaware Basin, Living Within Cash Flow
-
Canaccord Genuity Maintains a 'Hold' on Ultra Petroleum (UPL); Q3/11: Productivity Improving, Remain on Sidelines After Move
-
Canaccord Genuity Reiterates a 'Buy' on Petroleum Development (PETD); Q3/11: Higher Liquids Content, Lower Expenses, All Good
-
Canaccord Genuity Reiterates a 'Buy' on Bill Barrett (BBG); Q3/11: Uinta Basin Success, Oil Exploration Continues
-
Canaccord Genuity Downgrades Medifast (MED) to Hold
-
New Gold and Silver Quest Resources Execute Definitive Arrangement Agreement
-
Orosur Mining Inc Exercise of Share Options
-
Canaccord Genuity Maintains a 'Buy' on AtriCure Inc. (ATRC) Amid Mixed Results; Takeout Candidate?
-
Bloom Income & Growth Canadian Fund Closes Over Allotment
-
Bloom Income & Growth Canadian Fund Closes Over Allotment
-
Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Q3/11 Update: Dificid Sales Surpass Expectations
-
Canaccord Genuity Maintains a 'Buy' on Insulet Corporation (PODD); Q3/11 Results Light Due to One-time Issue, Patient Adoption Strong
-
Canaccord Genuity Maintains a 'Buy' on Jones Lang LaSalle (JLL); Adjusting Q4 Estimates
-
Canaccord Genuity Maintains a 'Buy' on Elster Group SE (ELT); Managing Well Through the Macro
-
Canaccord Genuity Maintains a 'Hold' on Echelon (ELON); Duke Disappoints, but Platform Progressing
-
Canaccord Genuity Maintains a 'Buy' on Medifast (MED); Direct Selling Momentum Lost
